Oncogenic PELP1 signaling is implicated in the progression of several cancers, including breast [12], endometrial [45], ovarian [46], salivary [47], prostate [14], lung [48], pancreas [49], and colon [50]. The gene discussed is PELP1; the disease is cancer.